| Tue, Jun 30, 2009 | | • | 10 Stocks Shaking the Market
at Motley Fool (Tue, Jun 30)
| | Fri, Jun 26, 2009 | | • | UPDATE - Ista wins U.S. panel support for eye itch drug
at Reuters (Fri, Jun 26)
| | • | FDA panel backs Ista drug for eye allergies
AP (Fri, Jun 26)
| | • | Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
PR Newswire (Fri, Jun 26)
| | Wed, Jun 24, 2009 | | • | FDA says Ista eye drug has no serious side effects
AP (Wed, Jun 24)
| | • | UPDATE - US FDA staff: No big safety issues with Ista drug
at Reuters (Wed, Jun 24)
| | Wed, Jun 17, 2009 | | • | A Look at ISTA's Strong Pipeline
at Seeking Alpha (Wed, Jun 17)
| | Thu, Jun 11, 2009 | | • | A Shooting STAAR in the Eye Care Sector
Indie Research (Thu, Jun 11)
| | Wed, Jun 10, 2009 | | • | Coverage initiated on ISTA Pharm by Sun Trust Rbsn Humphrey
Briefing.com (Wed, Jun 10)
| | Mon, Jun 8, 2009 | | • | ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
PR Newswire (Mon, Jun 8)
| | Wed, Jun 3, 2009 | | • | FDA and Clinical Trial Updates: ADLS, CLDA, GENZ, ISTA, Theratech
at Seeking Alpha (Wed, Jun 3)
| | Tue, Jun 2, 2009 | | • | 13 Extreme FDA Trades
at Seeking Alpha (Tue, Jun 2)
| | Mon, Jun 1, 2009 | | • | ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
PR Newswire (Mon, Jun 1)
| | Thu, May 21, 2009 | | • | ISTA PHARMACEUTICALS INC Financials
EDGAR Online Financials (Thu, May 21)
| | Tue, May 12, 2009 | | • | Form 10 K for Ista Pharmaceuticals
WILink (Tue, May 12)
| | • | ISTA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, May 12)
| | Thu, May 7, 2009 | | • | ISTA Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today
CCBN (Thu, May 7)
| | • | ISTA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, May 7)
| | • | ISTA Pharmaceuticals' First Quarter 2009 Revenue Increases 32% to $20.4 Million
PR Newswire (Thu, May 7)
| | • | ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting
PR Newswire (Thu, May 7)
|
Add ISTA News to My Yahoo!:
 
| |
|
0.62% Nasdaq 
0.09%
Headlines
